Introduction: Stroke remains a major cause of death and disability in Japan and worldwide. Detecting individuals at high risk for stroke to apply preventive approaches is recommended. This study aimed to develop a stroke risk prediction model among urban Japanese using cardiovascular risk factors. Methods: We followed 6,641 participants aged 30–79 years with neither a history of stroke nor coronary heart disease. The Cox proportional hazard model estimated the risk of stroke incidence adjusted for potential confounders at the baseline survey. The model’s performance was assessed using the receiver operating characteristic curve and the Hosmer-Lemeshow statistics. The internal validity of the risk model was tested using derivation and validation samples. Regression coefficients were used for score calculation. Results: During a median follow-up duration of 17.1 years, 372 participants developed stroke. A risk model including older age, current smoking, increased blood pressure, impaired fasting blood glucose and diabetes, chronic kidney disease, and atrial fibrillation predicted stroke incidence with an area under the curve = 0.76 and p value of the goodness of fit = 0.21. This risk model was shown to be internally valid (p value of the goodness of fit in the validation sample = 0.64). On a risk score from 0 to 26, the incidence of stroke for the categories 0–5, 6–7, 8–9, 10–11, 12–13, 14–15, and 16–26 was 1.1%, 2.1%, 5.4%, 8.2%, 9.0%, 13.5%, and 18.6%, respectively. Conclusion: We developed a new stroke risk model for the urban general population in Japan. Further research to determine the clinical practicality of this model is required.

1.
GBD 2019 Diseases and Injuries Collaborators
.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
.
Lancet
.
2020
;
396
(
10258
):
1204
22
. .
2.
Iso
H
.
A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches
.
EPMA J
.
2011
;
2
(
1
):
49
57
. .
3.
Cao
J
,
Eshak
ES
,
Liu
K
,
Yang
J
,
Gero
K
,
Liu
Z
,
An age-period-cohort analysis of stroke mortality attributable to low physical activity in China and Japan: data from the GBD Study 1990–2016
.
Sci Rep
.
2020
;
10
(
1
):
6525
. .
4.
Di Legge
S
,
Koch
G
,
Diomedi
M
,
Stanzione
P
,
Sallustio
F
.
Stroke prevention: managing modifiable risk factors
.
Stroke Res Treat
.
2012
;
2012
:
391538
. .
5.
Davis
TM
,
Millns
H
,
Stratton
IM
,
Holman
RR
,
Turner
RC
.
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29
.
Arch Intern Med
.
1999
;
159
:
1097
103
. .
6.
Almgren
T
,
Persson
B
,
Wilhelmsen
L
,
Rosengren
A
,
Andersson
OK
.
Stroke and coronary heart disease in treated hypertension: a prospective cohort study over three decades
.
J Intern Med
.
2005
;
257
:
496
502
. .
7.
Boysen
G
,
Nyboe
J
,
Appleyard
M
,
Sørensen
PS
,
Boas
J
,
Somnier
F
,
Stroke incidence and risk factors for stroke in Copenhagen, Denmark
.
Stroke
.
1988
;
19
:
1345
53
. .
8.
Kammersgaard
LP
,
Olsen
TS
.
Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study
.
Cerebrovasc Dis
.
2006
;
21
:
187
93
. .
9.
Lumley
T
,
Kronmal
RA
,
Cushman
M
,
Manolio
TA
,
Goldstein
SA
.
Stroke prediction score in the elderly: validation and web-based application
.
J Clin Epidemiol
.
2002
;
55
:
129
36
.
10.
Wang
TJ
,
Massaro
JM
,
Levy
D
,
Vasan
RS
,
Wolf
PA
,
D’Agostino
RB
,
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study
.
JAMA
.
2003
;
290
:
1049
56
. .
11.
Assmann
G
,
Schulte
H
,
Cullen
P
,
Seedorf
U
.
Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study
.
Eur J Clin Invest
.
2007
;
37
:
925
32
.
12.
Chambless
LE
,
Heiss
G
,
Shahar
E
,
Earp
MJ
,
Toole
J
.
Prediction of ischemic stroke risk in the atherosclerosis risk in Communities Study
.
Am J Epidemiol
.
2004
;
160
:
259
69
. .
13.
Wolf
PA
,
D’Agostino
RB
,
Belanger
AJ
,
Kannel
WB
.
Probability of stroke: a risk profile from the Framingham Study
.
Stroke
.
1991
;
22
:
312
8
. .
14.
Flueckiger
P
,
Longstreth
W
,
Herrington
D
,
Yeboah
J
.
Revised Framingham stroke risk score, nontraditional risk markers, and incident stroke in a multiethnic cohort
.
Stroke
.
2018
;
49
(
2
):
363
9
. .
15.
Dufouil
C
,
Beiser
A
,
McLure
LA
,
Wolf
PA
,
Tzourio
C
,
Howard
VJ
,
Revised Framingham stroke risk profile to reflect temporal trends
.
Circulation
.
2017
;
135
(
12
):
1145
59
. .
16.
Wang
W
,
Zhang
Y
,
Lee
ET
,
Howard
BV
,
Devereux
RB
,
Cole
SA
,
Risk factors and prediction of stroke in a population with high prevalence of diabetes: the Strong Heart Study
.
World J Cardiovasc Dis
.
2017
;
7
(
5
):
145
62
. .
17.
Park
KL
,
Budaj
A
,
Goldberg
RJ
,
Anderson
FA
 Jr
,
Agnelli
G
,
Kennelly
BM
,
Risk-prediction model for ischemic stroke in patients hospitalized with an acute coronary syndrome (from the global registry of acute coronary events [GRACE])
.
Am J Cardiol
.
2012
;
110
(
5
):
628
35
.
18.
Noda
H
,
Iso
H
,
Sairenchi
T
,
Irie
F
,
Fukasawa
N
,
Toriyama
Y
,
[Prediction of stroke, coronary heart disease, cardiovascular disease, cancer, and total death based on results of annual health checkups]
.
Nihon Koshu Eisei Zasshi
.
2006
;
53
(
4
):
265
76
.
19.
Arima
H
,
Yonemoto
K
,
Doi
Y
,
Ninomiya
T
,
Hata
J
,
Tanizaki
Y
,
Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study
.
Hypertens Res
.
2009
;
32
(
12
):
1119
22
. .
20.
Honda
T
,
Chen
S
,
Hata
J
,
Yoshida
D
,
Hirakawa
Y
,
Furuta
Y
,
Development and validation of a risk prediction model for atherosclerotic cardiovascular disease in Japanese adults: the Hisayama Study
.
J Atheroscler Thromb
.
2021
. Epub ahead of print.
21.
Ishikawa
S
,
Matsumoto
M
,
Kayaba
K
,
Gotoh
T
,
Nago
N
,
Tsutsumi
A
,
Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: the JMS Cohort Study
.
J Epidemiol
.
2009
;
19
(
2
):
101
6
.
22.
Yatsuya
H
,
Iso
H
,
Yamagishi
K
,
Kokubo
Y
,
Saito
I
,
Suzuki
K
,
Development of a point-based prediction model for the incidence of total stroke: Japan public health center study
.
Stroke
.
2013
;
44
(
5
):
1295
302
. .
23.
Yatsuya
H
,
Iso
H
,
Li
Y
,
Yamagishi
K
,
Kokubo
Y
,
Saito
I
,
Development of a risk equation for the incidence of coronary artery disease and ischemic stroke for middle-aged Japanese: Japan Public Health Center-Based Prospective Study
.
Circ J
.
2016
;
80
(
6
):
1386
95
. .
24.
Harada
A
,
Ueshima
H
,
Kinoshita
Y
,
Miura
K
,
Ohkubo
T
,
Asayama
K
,
Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study
.
Hypertens Res
.
2019
;
42
(
4
):
567
79
. .
25.
Suzuki
S
,
Yamashita
T
,
Okumura
K
,
Atarashi
H
,
Akao
M
,
Ogawa
H
,
Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy: pooled analysis of the Shinken database, J-RHYTHM registry, and Fushimi AF registry
.
Circ J
.
2015
;
79
(
2
):
432
8
. .
26.
Sairenchi
T
,
Yamagishi
K
,
Iso
H
,
Irie
F
,
Koba
A
,
Nagao
M
,
Atrial fibrillation with and without cardiovascular risk factors and stroke mortality
.
J Atheroscler Thromb
.
2021
;
28
(
3
):
241
8
. .
27.
Kokubo
Y
,
Watanabe
M
,
Higashiyama
A
,
Nakao
YM
,
Kusano
K
,
Miyamoto
Y
.
Development of a basic risk score for incident atrial fibrillation in a Japanese general population: the Suita Study
.
Circ J
.
2017
;
81
(
11
):
1580
8
. .
28.
Walker
AE
,
Robins
M
,
Weinfeld
FD
.
The national survey of stroke. Clinical findings
.
Stroke
.
1981
;
12
:
I13
44
.
29.
Friedewald
WT
,
Levy
RI
,
Fredrickson
DS
.
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
.
Clin Chem
.
1972
;
18
:
499
502
. .
30.
Imai
E
,
Horio
M
,
Nitta
K
,
Yamagata
K
,
Iseki
K
,
Hara
S
,
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease
.
Clin Exp Nephrol
.
2007
;
11
:
41
50
. .
31.
Nakai
M
,
Watanabe
M
,
Kokubo
Y
,
Nishimura
K
,
Higashiyama
A
,
Takegami
M
,
Development of a cardiovascular disease risk prediction model using the Suita Study, a population-based prospective cohort study in Japan
.
J Atheroscler Thromb
.
2020
;
27
(
11
):
1160
75
. .
32.
Lemeshow
S
,
Hosmer
DW
.
A review of goodness of fit statistics for use in the development of logistic regression models
.
Am J Epidemiol
.
1982
;
115
:
92
106
. .
33.
Nakayama
S
,
Satoh
M
,
Metoki
H
,
Murakami
T
,
Asayama
K
,
Hara
A
,
Lifetime risk of stroke stratified by chronic kidney disease and hypertension in the general Asian population: the Ohasama study
.
Hypertens Res
.
2021
;
44
:
866
73
. .
34.
Maeda
T
,
Nishi
T
,
Funakoshi
S
,
Tada
K
,
Tsuji
M
,
Satoh
A
,
Increased incident ischemic stroke risk in advanced kidney disease: a large-scale real-world data study
.
Am J Nephrol
.
2020
;
51
(
8
):
659
68
. .
35.
Inaguma
D
,
Imai
E
,
Takeuchi
A
,
Ohashi
Y
,
Watanabe
T
,
Nitta
K
,
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
.
Clin Exp Nephrol
.
2017
;
21
(
3
):
446
56
. .
36.
Kudo
K
,
Konta
T
,
Degawa
N
,
Saito
S
,
Kondo
R
,
Kayama
T
,
Relationship between kidney damage and stroke types in Japanese patients
.
Clin Exp Nephrol
.
2012
;
16
(
4
):
564
9
. .
37.
Nakatani
H
.
Population aging in Japan: policy transformation, sustainable development goals, universal health coverage, and social determinates of health
.
Glob Health Med
.
2019
;
1
(
1
):
3
10
. .
38.
Stewart
J
,
Manmathan
G
,
Wilkinson
P
.
Primary prevention of cardiovascular disease: a review of contemporary guidance and literature
.
JRSM Cardiovasc Dis
.
2017
;
6
:
2048004016687211
. .
39.
Arafa
A
,
Lee
HH
,
Eshak
ES
,
Shirai
K
,
Liu
K
,
Li
J
,
Modifiable risk factors for cardiovascular disease in Korea and Japan
.
Korean Circ J
.
2021
;
51
:
e81
.
40.
Tomioka
K
,
Kurumatani
N
,
Saeki
K
.
The association between education and smoking prevalence, independent of occupation: a nationally representative survey in Japan
.
J Epidemiol
.
2020
;
30
(
3
):
136
42
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.